By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55



Company News
Epigenomics AG Announces Commercial Launch Of Epi proColon In The U.S. 4/27/2016 8:33:45 AM
Epigenomics AG To Present Data On Novel Blood-Based Test For The Detection Of Lung Cancer At AACR Annual Meeting 2016 4/18/2016 9:40:30 AM
Epigenomics AG Receives FDA Approval For Epi proColon 4/13/2016 9:28:17 AM
BioChain Acquires China Rights To Epigenomics AG' Lung Cancer IVD 4/6/2016 10:16:13 AM
Epigenomics AG Enters Strategic License And Development Agreement With Biochain3/30/2016 8:51:05 AM
Epigenomics AG Reports Results For The Financial Year Ended December 31, 2015 And Provides Outlook For 2016 3/18/2016 9:19:30 AM
Epigenomics AG Receives FDA Notification About Status Of Pending Approval Decision For Epi proColon 1/8/2016 11:07:33 AM
Epigenomics AG: Bondholders Resolve On Amendment Of The Terms And Conditions Of The 2013 Convertible Bonds 12/18/2015 10:54:18 AM
Epigenomics AG Appeals Recent FDA Request For Additional Information 11/30/2015 10:24:05 AM
Epigenomics AG Announces 2015 Third Quarter And Nine Month Financial Results And Reports On Operational Highlights 11/18/2015 10:12:33 AM